HC Wainwright reissued their buy rating on shares of Kymera Therapeutics (NASDAQ:KYMR – Free Report) in a research report report published on Friday morning, Benzinga reports. The brokerage currently has a $85.00 target price on the stock. KYMR has been the subject of several other reports. Truist Financial started coverage on Kymera Therapeutics in a […]
Kymera Therapeutics (NASDAQ:KYMR) Shares Gap Up to $21 50 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) will be announcing its earnings results before the market opens on Thursday, August 3rd. Analysts expect the company to announce earnings of ($0.70) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. Kymera Therapeutics (NASDAQ:KYMR […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating)’s stock price was down 3.6% on Tuesday . The company traded as low as $25.09 and last traded at $25.35. Approximately 152,721 shares traded hands during trading, a decline of 70% from the average daily volume of 507,524 shares. The stock had previously closed at $26.29. Wall Street […]
AXQ Capital LP bought a new position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating) in the fourth quarter, Holdings Channel reports. The firm bought 10,939 shares of the company’s stock, valued at approximately $273,000. Other large investors have also recently added to or reduced their stakes in the company. Point72 Hong Kong […]